Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?
about
A Biocompatible Synthetic Lung Fluid Based on Human Respiratory Tract Lining Fluid Composition.The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma.Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs.Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary dDifferences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?Bioequivalence of inhaled drugs: fundamentals, challenges and perspectives.Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.Model-based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation.Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs.A pharmacokinetic simulation tool for inhaled corticosteroids.Pharmacokinetics of Orally Inhaled Drug Products.Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.Assessment methods of inhaled aerosols: technical aspects and applications.Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil functionHealth Effects Associated with Inhalation of Airborne Arsenic Arising from Mining OperationsA Partial Differential Equation Approach to Inhalation Physiologically Based Pharmacokinetic Modeling
P2860
Q30313138-197BCFA4-4F64-4687-85C7-756BF7163061Q33692813-6E8CD4D7-32BA-480B-8CF1-E1974EF97776Q35088023-87E2DAF0-9AC6-4836-B525-A2CA782DB5F9Q35768436-F7A0F404-AAD8-49F7-B65F-6F13D1882A50Q36679740-44BA6295-AE93-4D15-91CF-A9C6F3589DD5Q37362634-CD8D1995-0F00-42E4-B416-48115D5CF0B7Q37428235-1E104FDD-BB43-4387-8068-8FC528D5DCBAQ37937555-9A951168-39A1-4E00-8DAF-A1FF52E1E4F0Q38084738-94144952-535E-4550-A998-0F847DE08D77Q38930261-2EA35160-7FC0-404F-9B3B-5B775E71C8E6Q39794883-986CFDD3-5427-45AA-B565-029BBEFC8E0FQ40258577-1A324029-F120-49F8-B4B1-B3E2DE39BECFQ42507245-519547FF-F8F4-42B4-94DA-8B0CA293DA86Q42593027-076065C7-B8DA-439F-80E4-CE4AFE65A54BQ47096485-479C8093-84AA-4B02-B453-9BBF3A707BEEQ51808165-596FFF10-A222-4F76-93E9-FFA7BE2D01D9Q55440444-04643792-9D7D-49EB-985E-184942E595C5Q57074380-B1077882-F063-45A4-AD26-56ED1D160A98Q57541950-1185994A-FBD7-4CCE-A789-F79A8D56BD5BQ58764015-2C556087-ED6C-405B-8CED-0035F2F53769
P2860
Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Do airway clearance mechanisms ...... ts of inhaled corticosteroids?
@en
type
label
Do airway clearance mechanisms ...... ts of inhaled corticosteroids?
@en
prefLabel
Do airway clearance mechanisms ...... ts of inhaled corticosteroids?
@en
P2093
P1476
Do airway clearance mechanisms ...... ts of inhaled corticosteroids?
@en
P2093
Jarl Ingelf
Lars Borgström
Olof Selroos
Per Wollmer
Staffan Edsbäcker
P304
P356
10.1016/J.PUPT.2007.08.005
P577
2007-09-06T00:00:00Z